We unite science, talent, and technology to get ahead of disease together.
We prevent and treat disease with vaccines, specialty, and general medicines. We focus on science of the immune system, human genetics, and advanced technologies investing in four core therapeutic areas and future opportunities to impact health at scale. We operate responsibly for all our stakeholders by prioritising Innovation, Performance, and Trust.
At this year’s virtual ASN Kidney Week, we are proud to share eight data presentations from across our growing pipeline and portfolio of Specialty medicines, underscoring our commitment to drive innovation for people with kidney disease.
Topics:
– Basic Clinical Science Session
– APOL1 Epidemiology Causal Mechanisms and Therapeutics Are We There Yet
– Best of ASN Journals JASN CJASN and Kidney360
– Big Data for the Kidneys Including the Barry M Brenner MD Endowed Lectureship
– Cell Death and Clearance in AKI
– Cellular Senescence Premature Aging and CKD
– Challenge of Kidney Diseases in Patients with Monoclonal Gammopathy
– Control of Kidney Development
– COVID 19 and the Kidneys The Pediatric Perspective
– COVID 19 in Hemodialysis and Kidney Transplant Patients From Basic to Translational Science
– Determinants of Renal Transport Beyond the Usual Suspects
– Emerging Treatment Paradigms for CKD MBD
– Epigenetic and Epigenome Modifications and Diabetic Kidney Disease
– Essentially Non Essential Secondary Hypertension Updates
– From Biomarkers to Bioactivity Metabolites and Metabolomes in Kidney Diseases
– From the Lab to the Clinic iPSC Derived Organoids and Therapeutic Discovery
– Home Improvement Novel Mechanisms of Nephron Remodeling
– Impact of Metabolic Surgery on Diabetic Kidney Disease
– Improving Vascular Access Medicine Following the Science
– Its All About the Collagen
– Kidney as a Metabolic Organ Glucotoxicity and Lipotoxicity Including the Robert W Schrier MD Endowed Lectureship
– Kidney Genomics Discoveries and Implementation
– M2M2M in the Kidneys From Maps to Mechanisms to Medicines in Kidney Diseases
– Maladaptive Responses in AKI
– Metabolic Incompetence in AKI
– Multiple Hats of Intercalated Cells
– Neonatal Advanced Kidney Disease Updates Challenges and Future Steps
– Neural Control of Kidneys and Bladder Function
– New and Novel Pathways Implicated in the Development of Genetic Kidney Disease
– New Horizons in Genomic Sequencing for Patients with Kidney Diseases
– New Therapeutic Targets in AKI
– Recent Advances in Kidney Disease Research in China Joint ASN CSN Session
– Right Patient Right Test Right Time Integrating Genomic Sequencing into Clinical Practice
– Shedding Light on Cell Surface Proteins Uromodulin and Mucin 1
– Single Cell Signature of the Diabetic Kidney
– Small Giants in the Cell Organelles in the Kidney World
– The Pressure Is On Update on Mechanisms of Salt Sensitive Hypertension
– Thinking Beyond Tolvaptan Regulation of Aquaporin 2 and Water Handling
– Tolerance and Kidney Transplantation Where We Do Stand
– Tough Neighborhood Tissue Microenvironment and Kidney Fibrosis
– Uncovering a Molecular Basis for CKD MBD
– Update on Renal Amyloidosis and Fibrillary Glomerulonephritis
– Water Water Everywhere Not a Drop to Drink Update on Childhood Nephrotic Syndrome
– What to Target Insights into the Pathogenesis of Glomerular Disease
– Clinical Practice Session
– Advancing Peritoneal Dialysis for Higher Acuity Patients
– Better Diabetes and CKD Care by Moving from Evidence to Practice
– Beyond the Biopsy Diagnosing Rejection in 2021
– Biomarkers of Diabetic Kidney Disease How to Use Them
– Biomarkers Schmiomarkers Wheres the Beef
– Cardiovascular Disease in CKD The Heart of the Matter
– Case Studies in Glomerular Disease
– CKD and Heart Failure The Cardiorenal Connection
– Contemporary Management of Intoxications
– Controversy Conference KDIGO Target for Systolic BP in CKD of 120 mm Hg
– Developing a Workforce So That We Can Retire One Day
– Diet and CKD What to Eat When to Eat How to Eat
– Extracorporeal Blood Purification in Special Situations
– Glomerular Zebras What Do We Do
– Going the Extra Mile Improving Kidney Transplant Allocation Including the Garabed Eknoyan Endowed Lectureship
– Hypertension Across the Spectrum
– Immunotherapy and the Kidneys
– Improving Interobserver Agreement and Clinical Value of Renal Biopsies Including the Burton D Rose MD Endowed Lectureship
– Incorporating the Latest Clinical Studies into the Management of Your Patient with ANCA Vasculitis
– Integrating Point of Care Ultrasonography into Nephrology Practice
– Making the Art of Volume Assessment More Precise
– Management of Traditional Cardiovascular Risk Factors in Patients with ESKD
– Matters of the Heart CVD and Kidney Transplantation
– Nephrology Quiz and Questionnaire 2021
– On Call in the ICU
– Psychosocial Aspects of CKD
– Reducing Infections in Dialysis Across All Modalities
– Renal Biopsy Clinical Correlations 2021
– Starting at Home and Staying at Home
– State of the Science Designing Clinical Trials in Kidney Transplantation
– Strategies for Effective Kidney Disease Population Health Management
– Taking Conservative Kidney Management to the Next Level
– Taking Control Innovations in Hypertension Management
– Thrombotic Microangiopathies Beyond Hemolytic Uremic Syndrome Causes and Treatment Options
– Transition How Do We Optimize the Handoff
– Unmute Yourself Telenephrology
– Upping the Game Optimizing Medication Management in CKD
– Usual Suspects Diagnosing and Managing Common Glomerular Diseases Including the Michelle P Winn MD Endowed Lectureship
– Who What and Where for Newer Drugs for Diabetic Kidney Disease Joint ASN ADA Session
– Words Matter Standardizing CKD Nomenclature to Improve Patient Engagement and Communication Including the Celeste Castillo Lee Memorial Lectureship
– Educational Symposium
– Basics to Bedside State of the Art Rationale and Approach to Hyperkalemia in Kidney Diseases
– Current Therapies and Treatment Responses in Primary Focal Segmental Glomerulosclerosis and IgA Nephropathy
– Emerging Paradigms in Primary Hyperoxaluria Type 1
– Hepatorenal Syndrome Type 1 Advances in Management
– HIF PHIs Offer Hope for Anemia in CKD
– Knowing Your Options Understanding Therapies for Hyperkalemia Management to Aid Decision Making with Patients Treated with Hemodialysis
– Mineralocorticoid Receptors From Bedside to Bench and Back
– More Options and More to Come Update on the Management of Lupus Nephritis
– New Insights in Iron Deficiency Anemia Among Patients with Non Dialysis CKD
– Partners for Life Optimizing Collaboration of Community and Transplant Nephrologists
– SGLT2 Inhibitors Should We Put Them in the Water of Patients with CKD
– Update on Genetic Architecture and Therapy of Polycystic Kidney Diseases
– Update on the Epidemiology Pathogenesis and Treatment of CKD Associated Pruritus
– Uremic Toxin Removal with Dialysis Effects of Middle Molecule Clearance on Clinical Outcomes
– Event
– AKINow Pursuing Improved Care Through Science and a Clinical Connection
– Big Data The Promise to Help Address Complex Chronic Diseases While Reducing Health Disparities
– Catalyzing Patient Centered Innovation in Kidney Replacement Therapy
– COVID 19 Still Challenging After All These Years
– Future Proof Planning for Patient Care in a Changing World
– Inside the Beltway Including the Christopher R Blagg MD Endowed Lectureship in Kidney Diseases and Public Policy
– Transplant 2030
– United 4 Kidney Health Charting a Path Toward the Future of Kidney Medicine
– Women in Nephrology Annual Nancy E Gary Memorial Lecture
– Oral Abstract Session
– AKI Novel Mechanisms and Targets of Injury
– AKI Pathways Predictors and Prevention
– AKI Repair Stay Put or Transition to CKD
– Assessing Disease Risk in Children A Developmental Perspective
– CKD Cutting Edge of Mechanisms
– CKD MBD Potpourri Emerging Clinical and Basic Science in Mineral and Bone Disease
– COVID 19 and Kidney Diseases From Bedside to Bench
– Diabetic Kidney Disease Back to the Basics
– Diabetic Kidney Disease Recent Advances
– Dialysis Outcomes and Achievements
– Findings from Landmark Trials Other Kidney Trials and Observational Studies
– Fluid Electrolyte and Acid Base Disorders Basic and Clinical Research
– Genetic Kidney Diseases Research and New Hope
– Glomerular Diseases Antibodies Complement and Inflammatory Mediators
– Glomerular Diseases Trials Prognostic Markers and Podocyte Biology
– High Impact Clinical Trials
– Hypertension and Cardiovascular Risk in CKD
– Molecular Pathology Pathogenesis and Animal Models A Correlative Approach to Kidney Diseases
– Preventing Progression and Reassessing Race in GFR Estimation
– Special Session
Accelerating Up the Innovation Curve in Kidney Medicine
Advanced Social Media Tools for Education
Beyond the Head of the Table Uncovering the Power of the Patient Voice
Dont Forget About Me Implementing Post Transplant Education for Kidney Recipients
Ethical Challenges in Dialysis A Call to Action
Joint ASN NAM Plenary ASN Presidents Address COVID 19 Panel
Mind Your Business Introduction to Nephrology Economics and Leadership
NKF ASN Task Force to Reassess the Inclusion of Race in Diagnosing Kidney Diseases
Plenary Barbara Murphy Trailblazer Award John P Peters Award Donald W Seldin Young Investigator Award State of the Art Lecture
Plenary Midcareer Awards Homer W Smith Award State of the Art Lecture ASN Business Meeting
Plenary Robert G Narins Award Belding H Scribner Award State of the Art Lecture
– Translational Session
– Central Role of Phosphate in CKD MBD Including the Jack W Coburn MD Endowed Lectureship
– Diagnosis and Treatment of CVD and Heart Failure in ESKD
– European Nephrology Highlights Updates from the 2021 ERA EDTA Congress
– Mechanistic Insight and Pathologic Consequences of Crystalluria
– Microbiome Modulators of Immunology and Metabolism
– Non GWAS Approaches to Searching for Novel Genes for Diabetic Kidney Disease
– Novel Mechanisms of Organ Cross Talk in CKD MBD
– OGs of Big Data USRDS and DOPPS
– One Cell at a Time Application of Single Cell RNA Sequencing in Kidney Transplantation
– Race and Ethnicity in Kidney Diseases Joint ASN JSN Session
– Role of the Calcium Sensing Receptor in Non Parathyroid Tissues
– Role of the Cyst Microenvironment in the Origins and Progression of ADPKD
– Tackling Hyperkalemia Renewed Importance in Hypertension and CKD
